Skip to Main Content

Print | Bookmark | Email | Font Size: + |

September 30, 2021

Open Meeting Announcement – Nebulizers Proposed Local Coverage Determination (LCD)

On Wednesday, November 3, 2021 at 10 am ET, the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) will host a virtual public meeting to solicit stakeholder comments for the following proposed LCD:

Nebulizers (DL33370) – Proposing extension of treprostinil inhalation solution coverage, to treatment of pulmonary hypertension associated with interstitial lung disease; removal of treprostinil inhalation solution and iloprost coverage from treatment of chronic thromboembolic pulmonary hypertension

This virtual meeting is for the oral presentation of comments and for stakeholders interested in listening to the comments. In order for any oral comments to be considered, they must be submitted in writing through the formal comment process. Information related to the written comment process is available at Proposed Local Coverage Determinations (LCDs) Released for Comment – Nebulizers and Pneumatic Compression Devices.

Stakeholders interested in attending the virtual meeting and commenting must register by Thursday October 14, 2021 at 5 pm ET. Registration is available online at website.

By registering, you consent to your comments being recorded at the virtual meeting. You must not include any protected health information (PHI) or personally identifiable information (PII) in your comments.

We request that you confine your public comments at the virtual open meeting to the proposed changes. The medical directors appreciate that you may have comments about other criteria in the proposed LCD, and you are welcome to submit those in your written comments; however, the virtual open meeting is to solicit public feedback on the proposed LCD changes. We ask that comments from the same organization/manufacturer be consolidated and presented by a single representative or spokesperson.

Any material (such as slides) that a registrant will present during the virtual open meeting must be sent to by Thursday, October 21, 2021 at 5 pm ET. In the body of the email, please include the name of the presenter and the represented organization if applicable.

Advance registration is not required for stakeholders who only wish to listen to the virtual open meeting.

To access the virtual meeting via teleconference, use the following information:

Conference dial-in number:

US Toll free: 1-866-901-6455
Access Code: 884-280-042

Note: After joining the webinar, a telephone audio PIN will be provided to participants who registered to present oral comments.

The amount of time allotted for oral commenters' presentations will be determined by the number of commenters registered. Speaking time and order of commenters will be provided prior to the virtual meeting.

*IMPORTANT REMINDER: Suppliers and clinicians are cautioned not to make any changes based upon information contained in proposed LCDs. Proposed LCDs may be revised based upon the comments received. When all comments have been reviewed, revisions will be considered.

Refer to each DME MAC website for additional information, including access to the proposed LCDs.

Thank you for your participation in our policy development process.

Smitha M. Ballyamanda, MD, CAQSM
Medical Director, DME MAC Jurisdiction A
Noridian Healthcare Solutions, LLC
Robert D. Hoover, Jr., MD, MPH, FACP
Medical Director, DME MAC Jurisdiction C
CGS Administrators, LLC
Stacey V. Brennan, MD, FAAFP
Medical Director, DME MAC Jurisdiction B
CGS Administrators, LLC
Peter J. Gurk, MD, CPE, CHCQM
Medical Director, DME MAC, Jurisdiction D
Noridian Healthcare Solutions, LLC


26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved